| Authors: |
Jardine A; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK., Burke SK; Akebia Therapeutics, Inc., Cambridge, Massachusetts, USA., Luo W; Akebia Therapeutics, Inc., Cambridge, Massachusetts, USA., Minga T; Akebia Therapeutics, Inc., Cambridge, Massachusetts, USA., Sarnak MJ; Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA., Winkelmayer WC; Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Agarwal R; Department of Medicine, and Richard L. Roudebush Veterans Administration Medical Center, Indiana University School of Medicine, Indianapolis, Indiana, USA., Chertow GM; Departments of Medicine, Epidemiology and Population Health, and Health Policy, Stanford University School of Medicine, Palo Alto, California, USA., Eckardt KU; Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany., Koury MJ; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennesse, USA. |
